Authors


DeShawn Wilbern, MBA

Latest:

Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America

CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.


John N. Mafi, MD, MPH

Latest:

Impact of Telemedicine Use on Outpatient-Related CO2 Emissions: Estimate From a National Cohort

Telemedicine was associated with a monthly avoidance of greenhouse gas emissions equivalent to the emissions of 61,255 to 130,076 passenger vehicles.


Chiu-Mei Yeh, MS

Latest:

Hospital Partnership and Patient Outcomes Among Postacute Patients With Stroke

This article explores the patient-sharing relationships between acute hospitals and postacute hospitals and how these relationships influence patient discharge outcomes.


Jeanne Jiang, MS

Latest:

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.



James Frisbie, MD

Latest:

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.


Bob Kronemyer

Latest:

Frequency of Condomless Sex Among Women Using Reversible Methods of Contraception

A substudy of the Evidence for Contraceptive Options and HIV Outcomes trial, which compared 3 highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device or the levonorgestrel implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate.



Bo Lv, PhD

Latest:

How Do Primary Hospitals Enact Early Response to the Relaxation of COVID-19 Prevention and Control Measures? The Experience From Chengdu, China

This article examines how primary hospitals in Chengdu, China, responded to the relaxation of COVID-19 prevention and control measures in December 2022.


Austin S. Kilaru, MD

Latest:

An Accelerated Hospital Observation Pathway to Reduce Length of Stay for Patients With COVID-19

For select patients hospitalized due to COVID-19, an academic urban hospital implemented an observation pathway that incorporated mobile health technology, reducing hospital length of stay by more than 2 days.


Wen-Chih Wu, MD, MPH

Latest:

Implementation of Early Follow-up Care After Heart Failure Hospitalization

An early heart failure follow-up intervention succeeded in increasing referral to and completion of cardiology appointments within 7 days of discharge. The intervention was associated with lower risk of 30-day all-cause emergency department visits, all-cause hospitalizations, or death.


Aditi P. Sen, PhD, MA

Latest:

Medicare Advantage Coverage Restrictions for the Costliest Physician-Administered Drugs

Four large Medicare Advantage insurers manage access to expensive physician-administered drugs with a combination of prior authorization, step therapy, and Part D formulary design.


Eugene Wright, MD

Latest:

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.


Ryan Haumschild, PharmD, MS, MBA, CPEL

Latest:

Measuring What Matters: Evidence and End Points That Define Disability in MS

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that progression independent of relapse activity (PIRA) is the primary driver of confirmed disability progression in patients with multiple sclerosis (MS), with clinical parameters over 3 to 6 months being the most meaningful measures of treatment impact.


Maite López-Garrigós, PhD

Latest:

Management of Procalcitonin Test Overuse in an Emergency Department Through a Computer Algorithm

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.


Timothy J. Vogus, PhD

Latest:

Association of Physician Coordination With Interfacility Transfer Acceptance Timeliness

The authors reviewed physician-to-physician conversations during emergency transfer of patients with ST-segment elevation myocardial infarction and found that higher-quality physician coordination was associated with faster time to acceptance.


Shailender Swaminathan, PhD

Latest:

Comparison of Mortality Between Medicare Advantage and Traditional Medicare Beneficiaries With Kidney Failure

The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.


German Hernandez, MD, FASN, FACP

Latest:

Access to Therapy and Future Treatment Directions in Lupus Nephritis

German Hernandez, MD, FASN, FACP, and Ellen Ginzler, MD, MPH, discuss barriers to treatment access in lupus nephritis, and address future directions and unmet needs of the disease.


Yevgeniy Feyman, PhD

Latest:

Veterans Health Administration Benefit Value Has Little Effect on Reliance

Relying on veteran survey responses and novel actuarial data, the authors examine the relationship between benefit value and reliance on the Veterans Health Administration.


Joshua Greenblatt, BFA

Latest:

The Promise of Telehealth—a Cautionary Tale

Implications of Telehealth Use on the Future of Oncology Care


Mariam Zunnu Rain, BS

Latest:

Differences in Spending for Diabetes and Multiple Chronic Conditions in Michigan Medicare Beneficiaries

Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.


John Martin, PhD, MPH

Latest:

A Novel Approach to Attribute Responsible Physicians Using Inpatient Claims

The authors propose a novel approach in which physicians’ responsibility for inpatient stays is expressed through physician-specific attribution ratios informed by patient characteristics.


Qingting Wang, PhD

Latest:

Determinants of ICS Therapy Adherence in Patients With Asthma

This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China.


Seema Bhat, MD

Latest:

Reflections on 2024’s Progress in R/R CLL

Panelists discuss how the relapsed/refractory chronic lymphocytic leukemia treatment landscape evolved significantly in 2024 with expanded Bruton tyrosine kinase inhibitor options, growing real-world evidence for newer agents, and emerging combination strategies, while expressing optimism for future advances in personalized therapy approaches and novel drug development.


Nadia N. Hansel, MD

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.



Anne Leach, MS, RDN, LD

Latest:

Health Impacts of Health System Implementation of a Food-as-Medicine Strategy

This article describes the reach of a Food-as-Medicine strategy implemented by a regional health care system and its impact on adult participants’ cardiometabolic risk factors.


Esther Jando, MSHCM, RN, CCM

Latest:

Care Transitions for Young Adults With Special Health Care Needs

A Medicaid managed care plan developed a pilot program to assist special needs youth with transition to adult care. Case studies and discussion present findings.


Nathan Smith, PhD

Latest:

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.


William B. Miller, Jr, MD

Latest:

Contributor: Cellular Research Offers New Opportunities in Our Battle Against Cancer

William B. Miller, Jr, MD, evolutionary biologist, medical doctor, and author explains the importance of cellular research in finding inventive solutions to the growing burden of cancer.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo